Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02212652 · ClinicalTrials.gov registry record · NA

Vitamin D to Improve Nutrition Prior to Bariatric Surgery and Investigate the Relationship With Negative Outcomes

A NA study, sponsored by Johns Hopkins University.

Terminated
Registry status
NA
Development phase
70
Enrollment target

NCT02212652: Clinical Trial NA study, sponsored by Johns Hopkins University.

NCT02212652 is a NA study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02212652, a NA study, was terminated before completion, sponsored by Johns Hopkins University.

TERMINATED
Registry status
NA
Development phase
70 participants
Enrollment target

Study Summary

VISTA is looking to see if vitamin D supplements before bariatric surgery might improve vitamin D stores, which may help to prevent some complications like infections. Who can join this research study? * Approved to undergo bariatric surgery-Roux-en-Y Gastric Bypass or Vertical Sleeve Gastrectomy-at the Johns Hopkins Bayview Medical Center * 18 to 64 years of age * BMI of 35 to 49.9 kg/m2 * VitD insufficient or deficient prior to having surgery What will happen if a participant chooses to participate in this research study? * The participant will be randomly assigned (by chance) to receive either: * Standard care plus vitamin D supplements or * Standard care plus a placebo (contains no vitamin D) * Either would be provided at no cost to the participant * The investigators will ask the participant to complete a survey on the day of surgery regarding supplement use * The investigators will follow the participants medical record through the 12 month follow up clinic visit.

Primary Outcome

Improved post-operative vitamin D status as measured by serum 25(OH)D concentration.

Interventions

  • OTHER Placebo
  • OTHER Standard of Care
  • DIETARY_SUPPLEMENT Vitamin D

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2017-01
Est. Completion 2017-04
Phase NA
Johns Hopkins University

1,448 total trials

Why NCT02212652 stopped before completion

NCT02212652 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.

NCT02212652 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02212652 about?

NCT02212652 is a clinical study titled "Vitamin D to Improve Nutrition Prior to Bariatric Surgery and Investigate the Relationship With Negative Outcomes". VISTA is looking to see if vitamin D supplements before bariatric surgery might improve vitamin D stores, which may help to prevent some complications like infections. Who can join this research study? * Approved to undergo bariatric surgery-Roux-en-Y Gastric Bypass or Vertical Sleeve Gastrectomy-...

What is the current status of trial NCT02212652?

This trial is currently terminated. It is a NA study. The enrollment target is 70 participants. The study started on 2017-01. Estimated completion is 2017-04.

What interventions are being tested in trial NCT02212652?

The interventions under investigation include: Placebo (OTHER), Standard of Care (OTHER), Vitamin D (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02212652?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02212652's enrollment target sits among peer trials

70 1103rd of 2000 higher than 868 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02212652, the US trial registry maintained by the National Library of Medicine. NCT02212652 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.